nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.0021	0.00299	CcSEcCtD
Roflumilast—Ill-defined disorder—Irinotecan—pancreatic cancer	0.00208	0.00296	CcSEcCtD
Roflumilast—Urticaria—Tamoxifen—pancreatic cancer	0.00206	0.00294	CcSEcCtD
Roflumilast—Abdominal pain—Tamoxifen—pancreatic cancer	0.00205	0.00292	CcSEcCtD
Roflumilast—Abdominal pain—Erlotinib—pancreatic cancer	0.00203	0.00289	CcSEcCtD
Roflumilast—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.00203	0.00289	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00202	0.00288	CcSEcCtD
Roflumilast—Malaise—Irinotecan—pancreatic cancer	0.00202	0.00288	CcSEcCtD
Roflumilast—Vertigo—Irinotecan—pancreatic cancer	0.00201	0.00287	CcSEcCtD
Roflumilast—Weight decreased—Docetaxel—pancreatic cancer	0.00201	0.00287	CcSEcCtD
Roflumilast—Insomnia—Sunitinib—pancreatic cancer	0.00201	0.00286	CcSEcCtD
Roflumilast—Pneumonia—Docetaxel—pancreatic cancer	0.00199	0.00284	CcSEcCtD
Roflumilast—Infestation NOS—Docetaxel—pancreatic cancer	0.00198	0.00283	CcSEcCtD
Roflumilast—Infestation—Docetaxel—pancreatic cancer	0.00198	0.00283	CcSEcCtD
Roflumilast—Malaise—Gemcitabine—pancreatic cancer	0.00197	0.00281	CcSEcCtD
Roflumilast—Dyspepsia—Sunitinib—pancreatic cancer	0.00195	0.00279	CcSEcCtD
Roflumilast—Decreased appetite—Sunitinib—pancreatic cancer	0.00193	0.00275	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00192	0.00273	CcSEcCtD
Roflumilast—Fatigue—Sunitinib—pancreatic cancer	0.00191	0.00273	CcSEcCtD
Roflumilast—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00191	0.00272	CcSEcCtD
Roflumilast—Constipation—Sunitinib—pancreatic cancer	0.0019	0.00271	CcSEcCtD
Roflumilast—Discomfort—Irinotecan—pancreatic cancer	0.00188	0.00269	CcSEcCtD
Roflumilast—Renal failure acute—Epirubicin—pancreatic cancer	0.00188	0.00268	CcSEcCtD
Roflumilast—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.00187	0.00267	CcSEcCtD
Roflumilast—Asthenia—Tamoxifen—pancreatic cancer	0.00186	0.00265	CcSEcCtD
Roflumilast—Myalgia—Gemcitabine—pancreatic cancer	0.00186	0.00265	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00185	0.00263	CcSEcCtD
Roflumilast—Asthenia—Erlotinib—pancreatic cancer	0.00184	0.00262	CcSEcCtD
Roflumilast—Discomfort—Gemcitabine—pancreatic cancer	0.00184	0.00262	CcSEcCtD
Roflumilast—Myalgia—Fluorouracil—pancreatic cancer	0.00183	0.00261	CcSEcCtD
Roflumilast—Infection—Irinotecan—pancreatic cancer	0.00182	0.00259	CcSEcCtD
Roflumilast—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00182	0.00259	CcSEcCtD
Roflumilast—Discomfort—Fluorouracil—pancreatic cancer	0.00181	0.00257	CcSEcCtD
Roflumilast—Nervous system disorder—Irinotecan—pancreatic cancer	0.00179	0.00256	CcSEcCtD
Roflumilast—Rhinitis—Docetaxel—pancreatic cancer	0.00178	0.00254	CcSEcCtD
Roflumilast—Diarrhoea—Tamoxifen—pancreatic cancer	0.00177	0.00253	CcSEcCtD
Roflumilast—Infection—Gemcitabine—pancreatic cancer	0.00177	0.00252	CcSEcCtD
Roflumilast—Abdominal pain—Sunitinib—pancreatic cancer	0.00176	0.0025	CcSEcCtD
Roflumilast—Diarrhoea—Erlotinib—pancreatic cancer	0.00175	0.0025	CcSEcCtD
Roflumilast—Connective tissue disorder—Docetaxel—pancreatic cancer	0.00175	0.00249	CcSEcCtD
Roflumilast—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00175	0.00249	CcSEcCtD
Roflumilast—Infection—Fluorouracil—pancreatic cancer	0.00174	0.00248	CcSEcCtD
Roflumilast—Renal failure acute—Doxorubicin—pancreatic cancer	0.00174	0.00248	CcSEcCtD
Roflumilast—Skin disorder—Gemcitabine—pancreatic cancer	0.00173	0.00247	CcSEcCtD
Roflumilast—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00172	0.00245	CcSEcCtD
Roflumilast—Dizziness—Tamoxifen—pancreatic cancer	0.00171	0.00244	CcSEcCtD
Roflumilast—Dizziness—Erlotinib—pancreatic cancer	0.0017	0.00242	CcSEcCtD
Roflumilast—Insomnia—Irinotecan—pancreatic cancer	0.00165	0.00236	CcSEcCtD
Roflumilast—Cardiac disorder—Docetaxel—pancreatic cancer	0.00165	0.00235	CcSEcCtD
Roflumilast—Vomiting—Tamoxifen—pancreatic cancer	0.00165	0.00235	CcSEcCtD
Roflumilast—Hypersensitivity—Sunitinib—pancreatic cancer	0.00164	0.00233	CcSEcCtD
Roflumilast—Rash—Tamoxifen—pancreatic cancer	0.00163	0.00233	CcSEcCtD
Roflumilast—Dermatitis—Tamoxifen—pancreatic cancer	0.00163	0.00233	CcSEcCtD
Roflumilast—Vomiting—Erlotinib—pancreatic cancer	0.00163	0.00232	CcSEcCtD
Roflumilast—Headache—Tamoxifen—pancreatic cancer	0.00162	0.00232	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00162	0.00231	CcSEcCtD
Roflumilast—Rash—Erlotinib—pancreatic cancer	0.00162	0.00231	CcSEcCtD
Roflumilast—Dermatitis—Erlotinib—pancreatic cancer	0.00162	0.0023	CcSEcCtD
Roflumilast—Insomnia—Gemcitabine—pancreatic cancer	0.00161	0.0023	CcSEcCtD
Roflumilast—Dyspepsia—Irinotecan—pancreatic cancer	0.00161	0.0023	CcSEcCtD
Roflumilast—Immune system disorder—Docetaxel—pancreatic cancer	0.00161	0.00229	CcSEcCtD
Roflumilast—Headache—Erlotinib—pancreatic cancer	0.00161	0.00229	CcSEcCtD
Roflumilast—Mediastinal disorder—Docetaxel—pancreatic cancer	0.0016	0.00229	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.0016	0.00228	CcSEcCtD
Roflumilast—Asthenia—Sunitinib—pancreatic cancer	0.00159	0.00227	CcSEcCtD
Roflumilast—Decreased appetite—Irinotecan—pancreatic cancer	0.00159	0.00227	CcSEcCtD
Roflumilast—Insomnia—Fluorouracil—pancreatic cancer	0.00158	0.00226	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00158	0.00225	CcSEcCtD
Roflumilast—Fatigue—Irinotecan—pancreatic cancer	0.00158	0.00225	CcSEcCtD
Roflumilast—Constipation—Irinotecan—pancreatic cancer	0.00156	0.00223	CcSEcCtD
Roflumilast—Mental disorder—Docetaxel—pancreatic cancer	0.00156	0.00222	CcSEcCtD
Roflumilast—Malnutrition—Docetaxel—pancreatic cancer	0.00155	0.00221	CcSEcCtD
Roflumilast—Decreased appetite—Gemcitabine—pancreatic cancer	0.00155	0.00221	CcSEcCtD
Roflumilast—Dyspepsia—Fluorouracil—pancreatic cancer	0.00154	0.0022	CcSEcCtD
Roflumilast—Nausea—Tamoxifen—pancreatic cancer	0.00154	0.0022	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00154	0.00219	CcSEcCtD
Roflumilast—Fatigue—Gemcitabine—pancreatic cancer	0.00154	0.00219	CcSEcCtD
Roflumilast—Gastritis—Epirubicin—pancreatic cancer	0.00154	0.00219	CcSEcCtD
Roflumilast—Constipation—Gemcitabine—pancreatic cancer	0.00152	0.00217	CcSEcCtD
Roflumilast—Nausea—Erlotinib—pancreatic cancer	0.00152	0.00217	CcSEcCtD
Roflumilast—Decreased appetite—Fluorouracil—pancreatic cancer	0.00152	0.00217	CcSEcCtD
Roflumilast—Diarrhoea—Sunitinib—pancreatic cancer	0.00152	0.00217	CcSEcCtD
Roflumilast—Dysgeusia—Docetaxel—pancreatic cancer	0.00152	0.00216	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00151	0.00216	CcSEcCtD
Roflumilast—Feeling abnormal—Irinotecan—pancreatic cancer	0.00151	0.00215	CcSEcCtD
Roflumilast—Influenza—Epirubicin—pancreatic cancer	0.0015	0.00214	CcSEcCtD
Roflumilast—Back pain—Docetaxel—pancreatic cancer	0.0015	0.00214	CcSEcCtD
Roflumilast—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.0015	0.00213	CcSEcCtD
Roflumilast—Muscle spasms—Docetaxel—pancreatic cancer	0.00149	0.00212	CcSEcCtD
Roflumilast—Dizziness—Sunitinib—pancreatic cancer	0.00147	0.00209	CcSEcCtD
Roflumilast—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00147	0.00209	CcSEcCtD
Roflumilast—Abdominal pain—Irinotecan—pancreatic cancer	0.00145	0.00206	CcSEcCtD
Roflumilast—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00144	0.00206	CcSEcCtD
Roflumilast—Gastritis—Doxorubicin—pancreatic cancer	0.00142	0.00203	CcSEcCtD
Roflumilast—Vomiting—Sunitinib—pancreatic cancer	0.00141	0.00201	CcSEcCtD
Roflumilast—Rash—Sunitinib—pancreatic cancer	0.0014	0.002	CcSEcCtD
Roflumilast—Dermatitis—Sunitinib—pancreatic cancer	0.0014	0.00199	CcSEcCtD
Roflumilast—Urticaria—Fluorouracil—pancreatic cancer	0.00139	0.00198	CcSEcCtD
Roflumilast—Headache—Sunitinib—pancreatic cancer	0.00139	0.00198	CcSEcCtD
Roflumilast—Influenza—Doxorubicin—pancreatic cancer	0.00139	0.00198	CcSEcCtD
Roflumilast—Palpitations—Docetaxel—pancreatic cancer	0.00137	0.00195	CcSEcCtD
Roflumilast—Weight decreased—Epirubicin—pancreatic cancer	0.00136	0.00193	CcSEcCtD
Roflumilast—Hypersensitivity—Irinotecan—pancreatic cancer	0.00135	0.00192	CcSEcCtD
Roflumilast—Pneumonia—Epirubicin—pancreatic cancer	0.00134	0.00192	CcSEcCtD
Roflumilast—Infestation—Epirubicin—pancreatic cancer	0.00134	0.00191	CcSEcCtD
Roflumilast—Infestation NOS—Epirubicin—pancreatic cancer	0.00134	0.00191	CcSEcCtD
Roflumilast—Myalgia—Docetaxel—pancreatic cancer	0.00132	0.00188	CcSEcCtD
Roflumilast—Nausea—Sunitinib—pancreatic cancer	0.00132	0.00188	CcSEcCtD
Roflumilast—Asthenia—Irinotecan—pancreatic cancer	0.00131	0.00187	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00131	0.00187	CcSEcCtD
Roflumilast—Urinary tract infection—Epirubicin—pancreatic cancer	0.0013	0.00185	CcSEcCtD
Roflumilast—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00129	0.00184	CcSEcCtD
Roflumilast—Asthenia—Gemcitabine—pancreatic cancer	0.00128	0.00182	CcSEcCtD
Roflumilast—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00126	0.0018	CcSEcCtD
Roflumilast—Infection—Docetaxel—pancreatic cancer	0.00126	0.00179	CcSEcCtD
Roflumilast—Weight decreased—Doxorubicin—pancreatic cancer	0.00126	0.00179	CcSEcCtD
Roflumilast—Sinusitis—Epirubicin—pancreatic cancer	0.00125	0.00179	CcSEcCtD
Roflumilast—Diarrhoea—Irinotecan—pancreatic cancer	0.00125	0.00178	CcSEcCtD
Roflumilast—Pneumonia—Doxorubicin—pancreatic cancer	0.00124	0.00177	CcSEcCtD
Roflumilast—Nervous system disorder—Docetaxel—pancreatic cancer	0.00124	0.00177	CcSEcCtD
Roflumilast—Infestation NOS—Doxorubicin—pancreatic cancer	0.00124	0.00176	CcSEcCtD
Roflumilast—Infestation—Doxorubicin—pancreatic cancer	0.00124	0.00176	CcSEcCtD
Roflumilast—Skin disorder—Docetaxel—pancreatic cancer	0.00123	0.00175	CcSEcCtD
Roflumilast—Diarrhoea—Gemcitabine—pancreatic cancer	0.00122	0.00174	CcSEcCtD
Roflumilast—Dizziness—Irinotecan—pancreatic cancer	0.00121	0.00172	CcSEcCtD
Roflumilast—Rhinitis—Epirubicin—pancreatic cancer	0.0012	0.00172	CcSEcCtD
Roflumilast—Urinary tract infection—Doxorubicin—pancreatic cancer	0.0012	0.00171	CcSEcCtD
Roflumilast—Diarrhoea—Fluorouracil—pancreatic cancer	0.0012	0.00171	CcSEcCtD
Roflumilast—Connective tissue disorder—Epirubicin—pancreatic cancer	0.00118	0.00168	CcSEcCtD
Roflumilast—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.00117	0.00167	CcSEcCtD
Roflumilast—Vomiting—Irinotecan—pancreatic cancer	0.00116	0.00166	CcSEcCtD
Roflumilast—Sinusitis—Doxorubicin—pancreatic cancer	0.00116	0.00165	CcSEcCtD
Roflumilast—Dizziness—Fluorouracil—pancreatic cancer	0.00116	0.00165	CcSEcCtD
Roflumilast—Rash—Irinotecan—pancreatic cancer	0.00115	0.00164	CcSEcCtD
Roflumilast—Dermatitis—Irinotecan—pancreatic cancer	0.00115	0.00164	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00115	0.00164	CcSEcCtD
Roflumilast—Headache—Irinotecan—pancreatic cancer	0.00115	0.00163	CcSEcCtD
Roflumilast—Insomnia—Docetaxel—pancreatic cancer	0.00114	0.00163	CcSEcCtD
Roflumilast—Vomiting—Gemcitabine—pancreatic cancer	0.00113	0.00161	CcSEcCtD
Roflumilast—Rash—Gemcitabine—pancreatic cancer	0.00112	0.0016	CcSEcCtD
Roflumilast—Dermatitis—Gemcitabine—pancreatic cancer	0.00112	0.0016	CcSEcCtD
Roflumilast—Headache—Gemcitabine—pancreatic cancer	0.00112	0.00159	CcSEcCtD
Roflumilast—Cardiac disorder—Epirubicin—pancreatic cancer	0.00111	0.00159	CcSEcCtD
Roflumilast—Vomiting—Fluorouracil—pancreatic cancer	0.00111	0.00159	CcSEcCtD
Roflumilast—Rhinitis—Doxorubicin—pancreatic cancer	0.00111	0.00159	CcSEcCtD
Roflumilast—Dyspepsia—Docetaxel—pancreatic cancer	0.00111	0.00159	CcSEcCtD
Roflumilast—Rash—Fluorouracil—pancreatic cancer	0.0011	0.00157	CcSEcCtD
Roflumilast—Dermatitis—Fluorouracil—pancreatic cancer	0.0011	0.00157	CcSEcCtD
Roflumilast—Decreased appetite—Docetaxel—pancreatic cancer	0.0011	0.00157	CcSEcCtD
Roflumilast—Headache—Fluorouracil—pancreatic cancer	0.0011	0.00156	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00109	0.00156	CcSEcCtD
Roflumilast—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00109	0.00156	CcSEcCtD
Roflumilast—Fatigue—Docetaxel—pancreatic cancer	0.00109	0.00155	CcSEcCtD
Roflumilast—Nausea—Irinotecan—pancreatic cancer	0.00109	0.00155	CcSEcCtD
Roflumilast—Immune system disorder—Epirubicin—pancreatic cancer	0.00108	0.00155	CcSEcCtD
Roflumilast—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00108	0.00154	CcSEcCtD
Roflumilast—Constipation—Docetaxel—pancreatic cancer	0.00108	0.00154	CcSEcCtD
Roflumilast—Nausea—Gemcitabine—pancreatic cancer	0.00106	0.00151	CcSEcCtD
Roflumilast—Mental disorder—Epirubicin—pancreatic cancer	0.00105	0.0015	CcSEcCtD
Roflumilast—Malnutrition—Epirubicin—pancreatic cancer	0.00104	0.00149	CcSEcCtD
Roflumilast—Feeling abnormal—Docetaxel—pancreatic cancer	0.00104	0.00149	CcSEcCtD
Roflumilast—Nausea—Fluorouracil—pancreatic cancer	0.00104	0.00148	CcSEcCtD
Roflumilast—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00103	0.00147	CcSEcCtD
Roflumilast—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00103	0.00147	CcSEcCtD
Roflumilast—Tension—Epirubicin—pancreatic cancer	0.00103	0.00146	CcSEcCtD
Roflumilast—Dysgeusia—Epirubicin—pancreatic cancer	0.00102	0.00146	CcSEcCtD
Roflumilast—Nervousness—Epirubicin—pancreatic cancer	0.00101	0.00145	CcSEcCtD
Roflumilast—Back pain—Epirubicin—pancreatic cancer	0.00101	0.00144	CcSEcCtD
Roflumilast—Muscle spasms—Epirubicin—pancreatic cancer	0.001	0.00143	CcSEcCtD
Roflumilast—Immune system disorder—Doxorubicin—pancreatic cancer	0.001	0.00143	CcSEcCtD
Roflumilast—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.001	0.00143	CcSEcCtD
Roflumilast—Abdominal pain—Docetaxel—pancreatic cancer	0.000999	0.00142	CcSEcCtD
Roflumilast—Mental disorder—Doxorubicin—pancreatic cancer	0.000973	0.00139	CcSEcCtD
Roflumilast—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000969	0.00138	CcSEcCtD
Roflumilast—Malnutrition—Doxorubicin—pancreatic cancer	0.000967	0.00138	CcSEcCtD
Roflumilast—Tension—Doxorubicin—pancreatic cancer	0.000949	0.00135	CcSEcCtD
Roflumilast—Dysgeusia—Doxorubicin—pancreatic cancer	0.000947	0.00135	CcSEcCtD
Roflumilast—Malaise—Epirubicin—pancreatic cancer	0.000942	0.00134	CcSEcCtD
Roflumilast—Nervousness—Doxorubicin—pancreatic cancer	0.000939	0.00134	CcSEcCtD
Roflumilast—Vertigo—Epirubicin—pancreatic cancer	0.000939	0.00134	CcSEcCtD
Roflumilast—Back pain—Doxorubicin—pancreatic cancer	0.000935	0.00133	CcSEcCtD
Roflumilast—Hypersensitivity—Docetaxel—pancreatic cancer	0.000931	0.00133	CcSEcCtD
Roflumilast—Muscle spasms—Doxorubicin—pancreatic cancer	0.00093	0.00133	CcSEcCtD
Roflumilast—Palpitations—Epirubicin—pancreatic cancer	0.000923	0.00132	CcSEcCtD
Roflumilast—Asthenia—Docetaxel—pancreatic cancer	0.000907	0.00129	CcSEcCtD
Roflumilast—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000897	0.00128	CcSEcCtD
Roflumilast—Myalgia—Epirubicin—pancreatic cancer	0.00089	0.00127	CcSEcCtD
Roflumilast—Anxiety—Epirubicin—pancreatic cancer	0.000886	0.00126	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000883	0.00126	CcSEcCtD
Roflumilast—Discomfort—Epirubicin—pancreatic cancer	0.000879	0.00125	CcSEcCtD
Roflumilast—Malaise—Doxorubicin—pancreatic cancer	0.000872	0.00124	CcSEcCtD
Roflumilast—Vertigo—Doxorubicin—pancreatic cancer	0.000869	0.00124	CcSEcCtD
Roflumilast—Diarrhoea—Docetaxel—pancreatic cancer	0.000865	0.00123	CcSEcCtD
Roflumilast—Palpitations—Doxorubicin—pancreatic cancer	0.000854	0.00122	CcSEcCtD
Roflumilast—Infection—Epirubicin—pancreatic cancer	0.000847	0.00121	CcSEcCtD
Roflumilast—Nervous system disorder—Epirubicin—pancreatic cancer	0.000836	0.00119	CcSEcCtD
Roflumilast—Dizziness—Docetaxel—pancreatic cancer	0.000836	0.00119	CcSEcCtD
Roflumilast—Skin disorder—Epirubicin—pancreatic cancer	0.000828	0.00118	CcSEcCtD
Roflumilast—Myalgia—Doxorubicin—pancreatic cancer	0.000823	0.00117	CcSEcCtD
Roflumilast—Anxiety—Doxorubicin—pancreatic cancer	0.00082	0.00117	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000817	0.00117	CcSEcCtD
Roflumilast—Discomfort—Doxorubicin—pancreatic cancer	0.000813	0.00116	CcSEcCtD
Roflumilast—Vomiting—Docetaxel—pancreatic cancer	0.000804	0.00115	CcSEcCtD
Roflumilast—Rash—Docetaxel—pancreatic cancer	0.000797	0.00114	CcSEcCtD
Roflumilast—Dermatitis—Docetaxel—pancreatic cancer	0.000796	0.00114	CcSEcCtD
Roflumilast—Headache—Docetaxel—pancreatic cancer	0.000792	0.00113	CcSEcCtD
Roflumilast—Infection—Doxorubicin—pancreatic cancer	0.000784	0.00112	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000777	0.00111	CcSEcCtD
Roflumilast—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000774	0.0011	CcSEcCtD
Roflumilast—Insomnia—Epirubicin—pancreatic cancer	0.000771	0.0011	CcSEcCtD
Roflumilast—Skin disorder—Doxorubicin—pancreatic cancer	0.000766	0.00109	CcSEcCtD
Roflumilast—Nausea—Docetaxel—pancreatic cancer	0.000751	0.00107	CcSEcCtD
Roflumilast—Dyspepsia—Epirubicin—pancreatic cancer	0.000751	0.00107	CcSEcCtD
Roflumilast—Decreased appetite—Epirubicin—pancreatic cancer	0.000741	0.00106	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000736	0.00105	CcSEcCtD
Roflumilast—Fatigue—Epirubicin—pancreatic cancer	0.000735	0.00105	CcSEcCtD
Roflumilast—Constipation—Epirubicin—pancreatic cancer	0.000729	0.00104	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000719	0.00102	CcSEcCtD
Roflumilast—Insomnia—Doxorubicin—pancreatic cancer	0.000714	0.00102	CcSEcCtD
Roflumilast—Feeling abnormal—Epirubicin—pancreatic cancer	0.000703	0.001	CcSEcCtD
Roflumilast—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000697	0.000994	CcSEcCtD
Roflumilast—Dyspepsia—Doxorubicin—pancreatic cancer	0.000695	0.00099	CcSEcCtD
Roflumilast—Decreased appetite—Doxorubicin—pancreatic cancer	0.000686	0.000978	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000681	0.000971	CcSEcCtD
Roflumilast—Fatigue—Doxorubicin—pancreatic cancer	0.00068	0.00097	CcSEcCtD
Roflumilast—Urticaria—Epirubicin—pancreatic cancer	0.000677	0.000966	CcSEcCtD
Roflumilast—Constipation—Doxorubicin—pancreatic cancer	0.000675	0.000962	CcSEcCtD
Roflumilast—Abdominal pain—Epirubicin—pancreatic cancer	0.000674	0.000961	CcSEcCtD
Roflumilast—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00065	0.000927	CcSEcCtD
Roflumilast—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000645	0.00092	CcSEcCtD
Roflumilast—Hypersensitivity—Epirubicin—pancreatic cancer	0.000628	0.000896	CcSEcCtD
Roflumilast—Urticaria—Doxorubicin—pancreatic cancer	0.000627	0.000894	CcSEcCtD
Roflumilast—Abdominal pain—Doxorubicin—pancreatic cancer	0.000624	0.000889	CcSEcCtD
Roflumilast—Asthenia—Epirubicin—pancreatic cancer	0.000612	0.000872	CcSEcCtD
Roflumilast—Diarrhoea—Epirubicin—pancreatic cancer	0.000583	0.000832	CcSEcCtD
Roflumilast—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000581	0.000829	CcSEcCtD
Roflumilast—Asthenia—Doxorubicin—pancreatic cancer	0.000566	0.000807	CcSEcCtD
Roflumilast—Dizziness—Epirubicin—pancreatic cancer	0.000564	0.000804	CcSEcCtD
Roflumilast—Vomiting—Epirubicin—pancreatic cancer	0.000542	0.000773	CcSEcCtD
Roflumilast—Diarrhoea—Doxorubicin—pancreatic cancer	0.00054	0.00077	CcSEcCtD
Roflumilast—Rash—Epirubicin—pancreatic cancer	0.000538	0.000767	CcSEcCtD
Roflumilast—Dermatitis—Epirubicin—pancreatic cancer	0.000537	0.000766	CcSEcCtD
Roflumilast—Headache—Epirubicin—pancreatic cancer	0.000534	0.000762	CcSEcCtD
Roflumilast—Dizziness—Doxorubicin—pancreatic cancer	0.000522	0.000744	CcSEcCtD
Roflumilast—Nausea—Epirubicin—pancreatic cancer	0.000507	0.000722	CcSEcCtD
Roflumilast—Vomiting—Doxorubicin—pancreatic cancer	0.000502	0.000715	CcSEcCtD
Roflumilast—Rash—Doxorubicin—pancreatic cancer	0.000498	0.000709	CcSEcCtD
Roflumilast—Dermatitis—Doxorubicin—pancreatic cancer	0.000497	0.000709	CcSEcCtD
Roflumilast—Headache—Doxorubicin—pancreatic cancer	0.000494	0.000705	CcSEcCtD
Roflumilast—Nausea—Doxorubicin—pancreatic cancer	0.000469	0.000668	CcSEcCtD
Roflumilast—PDE4D—Signaling Pathways—CCKAR—pancreatic cancer	0.000386	0.00129	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PTHLH—pancreatic cancer	0.000383	0.00128	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCK—pancreatic cancer	0.000383	0.00128	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PTCH1—pancreatic cancer	0.000383	0.00128	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—JAG2—pancreatic cancer	0.000374	0.00125	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CNR2—pancreatic cancer	0.000373	0.00125	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GLP1R—pancreatic cancer	0.000373	0.00125	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HEY1—pancreatic cancer	0.000371	0.00124	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SCT—pancreatic cancer	0.000371	0.00124	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MEN1—pancreatic cancer	0.000369	0.00123	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCKAR—pancreatic cancer	0.000367	0.00123	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—JAG2—pancreatic cancer	0.000356	0.00119	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCK—pancreatic cancer	0.000354	0.00119	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SHH—pancreatic cancer	0.000352	0.00118	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MEN1—pancreatic cancer	0.000351	0.00118	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SST—pancreatic cancer	0.00035	0.00117	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NOTCH4—pancreatic cancer	0.000349	0.00117	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IAPP—pancreatic cancer	0.000347	0.00116	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000345	0.00116	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CNR2—pancreatic cancer	0.000345	0.00116	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GLP1R—pancreatic cancer	0.000345	0.00116	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—JAG1—pancreatic cancer	0.000343	0.00115	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NOTCH3—pancreatic cancer	0.000341	0.00114	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCKAR—pancreatic cancer	0.00034	0.00114	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SHH—pancreatic cancer	0.000335	0.00112	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PTCH1—pancreatic cancer	0.000333	0.00112	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PTHLH—pancreatic cancer	0.000333	0.00112	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NOTCH4—pancreatic cancer	0.000333	0.00111	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IAPP—pancreatic cancer	0.000331	0.00111	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—JAG2—pancreatic cancer	0.000329	0.0011	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MEN1—pancreatic cancer	0.000325	0.00109	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CNR1—pancreatic cancer	0.000323	0.00108	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PTHLH—pancreatic cancer	0.000317	0.00106	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PTCH1—pancreatic cancer	0.000317	0.00106	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000314	0.00105	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GCG—pancreatic cancer	0.000312	0.00105	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SHH—pancreatic cancer	0.00031	0.00104	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NOTCH4—pancreatic cancer	0.000308	0.00103	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IAPP—pancreatic cancer	0.000306	0.00102	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SST—pancreatic cancer	0.000305	0.00102	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000304	0.00102	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000301	0.00101	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—JAG1—pancreatic cancer	0.000298	0.000999	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AGTR1—pancreatic cancer	0.000298	0.000998	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NOTCH3—pancreatic cancer	0.000297	0.000995	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PTHLH—pancreatic cancer	0.000294	0.000983	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PTCH1—pancreatic cancer	0.000294	0.000983	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—STK11—pancreatic cancer	0.000294	0.000983	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SST—pancreatic cancer	0.00029	0.000972	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000286	0.000959	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—JAG1—pancreatic cancer	0.000284	0.000951	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NOTCH3—pancreatic cancer	0.000283	0.000947	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CNR1—pancreatic cancer	0.000281	0.000943	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000276	0.000924	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000273	0.000915	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GCG—pancreatic cancer	0.000272	0.00091	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SST—pancreatic cancer	0.000269	0.000899	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CNR1—pancreatic cancer	0.000268	0.000897	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000265	0.000887	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000265	0.000887	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000264	0.000886	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—JAG1—pancreatic cancer	0.000263	0.00088	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NOTCH3—pancreatic cancer	0.000262	0.000877	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PIK3CG—pancreatic cancer	0.00026	0.000871	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AGTR1—pancreatic cancer	0.000259	0.000868	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GCG—pancreatic cancer	0.000259	0.000866	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SMAD4—pancreatic cancer	0.000257	0.000861	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—STK11—pancreatic cancer	0.000256	0.000856	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000254	0.000852	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000252	0.000843	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HES1—pancreatic cancer	0.000251	0.000841	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CNR1—pancreatic cancer	0.000248	0.00083	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AGTR1—pancreatic cancer	0.000247	0.000827	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—STK11—pancreatic cancer	0.000243	0.000815	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000241	0.000806	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PIK3CB—pancreatic cancer	0.00024	0.000805	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PIK3CD—pancreatic cancer	0.00024	0.000804	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GCG—pancreatic cancer	0.000239	0.000802	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000233	0.00078	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—CXCL8—pancreatic cancer	0.000231	0.000774	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.00023	0.000772	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000229	0.000765	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AGTR1—pancreatic cancer	0.000228	0.000765	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—STK11—pancreatic cancer	0.000225	0.000754	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SMAD4—pancreatic cancer	0.000224	0.00075	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000221	0.000742	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TERT—pancreatic cancer	0.00022	0.000737	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000219	0.000735	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HES1—pancreatic cancer	0.000219	0.000732	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SMAD4—pancreatic cancer	0.000213	0.000714	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000211	0.000708	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000211	0.000706	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HIF1A—pancreatic cancer	0.00021	0.000705	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TSC2—pancreatic cancer	0.00021	0.000703	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000209	0.000701	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HES1—pancreatic cancer	0.000208	0.000697	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APOE—pancreatic cancer	0.000205	0.000688	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000203	0.00068	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—KDR—pancreatic cancer	0.000201	0.000674	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CXCL8—pancreatic cancer	0.000201	0.000674	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000199	0.000667	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SMAD4—pancreatic cancer	0.000197	0.00066	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000195	0.000653	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HES1—pancreatic cancer	0.000192	0.000645	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TERT—pancreatic cancer	0.000191	0.000641	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CXCL8—pancreatic cancer	0.000191	0.000641	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NFKBIA—pancreatic cancer	0.000191	0.000641	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NOTCH1—pancreatic cancer	0.00019	0.000635	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3CG—pancreatic cancer	0.000185	0.000621	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—NRAS—pancreatic cancer	0.000185	0.000621	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000184	0.000617	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—EGF—pancreatic cancer	0.000183	0.000614	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HIF1A—pancreatic cancer	0.000183	0.000613	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TSC2—pancreatic cancer	0.000183	0.000612	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TERT—pancreatic cancer	0.000182	0.00061	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APOE—pancreatic cancer	0.000179	0.000599	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CXCL8—pancreatic cancer	0.000177	0.000593	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—KDR—pancreatic cancer	0.000175	0.000587	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HIF1A—pancreatic cancer	0.000174	0.000584	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TSC2—pancreatic cancer	0.000174	0.000582	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOE—pancreatic cancer	0.00017	0.00057	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—EGFR—pancreatic cancer	0.000169	0.000566	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TERT—pancreatic cancer	0.000169	0.000565	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—KDR—pancreatic cancer	0.000167	0.000558	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NFKBIA—pancreatic cancer	0.000167	0.000558	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NOTCH1—pancreatic cancer	0.000165	0.000553	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3CD—pancreatic cancer	0.000163	0.000546	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000161	0.000541	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3CG—pancreatic cancer	0.000161	0.00054	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—NRAS—pancreatic cancer	0.000161	0.00054	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HIF1A—pancreatic cancer	0.000161	0.00054	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TSC2—pancreatic cancer	0.000161	0.000539	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—KRAS—pancreatic cancer	0.00016	0.000534	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—EGF—pancreatic cancer	0.000159	0.000534	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000159	0.000531	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOE—pancreatic cancer	0.000157	0.000527	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NOTCH1—pancreatic cancer	0.000157	0.000526	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—KDR—pancreatic cancer	0.000154	0.000517	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3CG—pancreatic cancer	0.000154	0.000514	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—NRAS—pancreatic cancer	0.000154	0.000514	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—EGF—pancreatic cancer	0.000152	0.000508	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—EGFR—pancreatic cancer	0.000147	0.000492	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NFKBIA—pancreatic cancer	0.000147	0.000491	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000147	0.000491	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NOTCH1—pancreatic cancer	0.000145	0.000487	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3CG—pancreatic cancer	0.000142	0.000476	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—NRAS—pancreatic cancer	0.000142	0.000476	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3CB—pancreatic cancer	0.000142	0.000476	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3CD—pancreatic cancer	0.000142	0.000475	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.00014	0.000471	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—EGF—pancreatic cancer	0.00014	0.00047	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—EGFR—pancreatic cancer	0.00014	0.000469	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—KRAS—pancreatic cancer	0.000139	0.000465	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CXCL8—pancreatic cancer	0.000136	0.000457	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HRAS—pancreatic cancer	0.000136	0.000454	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3CD—pancreatic cancer	0.000135	0.000452	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000134	0.000448	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—KRAS—pancreatic cancer	0.000132	0.000443	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—AKT1—pancreatic cancer	0.000132	0.000442	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CASP3—pancreatic cancer	0.000131	0.000437	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—EGFR—pancreatic cancer	0.000129	0.000434	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000128	0.000427	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCND1—pancreatic cancer	0.000127	0.000426	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CTNNB1—pancreatic cancer	0.000126	0.000422	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3CD—pancreatic cancer	0.000125	0.000418	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000124	0.000414	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3CB—pancreatic cancer	0.000124	0.000414	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MMP9—pancreatic cancer	0.000123	0.000413	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PTEN—pancreatic cancer	0.000123	0.000411	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—KRAS—pancreatic cancer	0.000122	0.00041	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000121	0.000407	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—AKT1—pancreatic cancer	0.00012	0.000401	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CXCL8—pancreatic cancer	0.000119	0.000398	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HRAS—pancreatic cancer	0.000118	0.000395	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3CB—pancreatic cancer	0.000118	0.000394	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—AKT1—pancreatic cancer	0.000115	0.000384	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SRC—pancreatic cancer	0.000114	0.000381	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CASP3—pancreatic cancer	0.000114	0.000381	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CXCL8—pancreatic cancer	0.000113	0.000379	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000112	0.000376	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HRAS—pancreatic cancer	0.000112	0.000376	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—VEGFA—pancreatic cancer	0.000111	0.000371	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCND1—pancreatic cancer	0.000111	0.000371	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—STAT3—pancreatic cancer	0.00011	0.000368	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CTNNB1—pancreatic cancer	0.00011	0.000367	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NRAS—pancreatic cancer	0.000109	0.000367	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—AKT1—pancreatic cancer	0.000109	0.000366	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3CB—pancreatic cancer	0.000109	0.000365	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CASP3—pancreatic cancer	0.000108	0.000362	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MMP9—pancreatic cancer	0.000107	0.00036	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PTEN—pancreatic cancer	0.000107	0.000358	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCND1—pancreatic cancer	0.000105	0.000353	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CXCL8—pancreatic cancer	0.000105	0.00035	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CTNNB1—pancreatic cancer	0.000104	0.000349	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—AKT1—pancreatic cancer	0.000104	0.000349	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HRAS—pancreatic cancer	0.000104	0.000348	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MMP9—pancreatic cancer	0.000102	0.000343	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MYC—pancreatic cancer	0.000102	0.000342	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TGFB1—pancreatic cancer	0.000102	0.000341	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PTEN—pancreatic cancer	0.000102	0.000341	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—AKT1—pancreatic cancer	0.000101	0.000339	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CASP3—pancreatic cancer	0.0001	0.000335	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—EGFR—pancreatic cancer	9.97e-05	0.000334	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—AKT1—pancreatic cancer	9.92e-05	0.000332	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SRC—pancreatic cancer	9.91e-05	0.000332	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCND1—pancreatic cancer	9.75e-05	0.000326	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CTNNB1—pancreatic cancer	9.65e-05	0.000323	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—VEGFA—pancreatic cancer	9.65e-05	0.000323	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—STAT3—pancreatic cancer	9.55e-05	0.00032	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NRAS—pancreatic cancer	9.53e-05	0.000319	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MMP9—pancreatic cancer	9.46e-05	0.000317	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SRC—pancreatic cancer	9.43e-05	0.000316	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—KRAS—pancreatic cancer	9.42e-05	0.000316	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PTEN—pancreatic cancer	9.41e-05	0.000315	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—VEGFA—pancreatic cancer	9.18e-05	0.000308	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—AKT1—pancreatic cancer	9.18e-05	0.000307	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—STAT3—pancreatic cancer	9.09e-05	0.000305	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NRAS—pancreatic cancer	9.07e-05	0.000304	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MYC—pancreatic cancer	8.88e-05	0.000297	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TGFB1—pancreatic cancer	8.86e-05	0.000297	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SRC—pancreatic cancer	8.73e-05	0.000292	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—EGFR—pancreatic cancer	8.68e-05	0.000291	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3CA—pancreatic cancer	8.66e-05	0.00029	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—VEGFA—pancreatic cancer	8.5e-05	0.000285	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MYC—pancreatic cancer	8.45e-05	0.000283	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TGFB1—pancreatic cancer	8.43e-05	0.000282	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—STAT3—pancreatic cancer	8.41e-05	0.000282	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NRAS—pancreatic cancer	8.39e-05	0.000281	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TP53—pancreatic cancer	8.37e-05	0.00028	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—EGFR—pancreatic cancer	8.27e-05	0.000277	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—KRAS—pancreatic cancer	8.2e-05	0.000275	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HRAS—pancreatic cancer	8.01e-05	0.000268	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MYC—pancreatic cancer	7.82e-05	0.000262	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—KRAS—pancreatic cancer	7.81e-05	0.000262	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TGFB1—pancreatic cancer	7.8e-05	0.000261	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—EGFR—pancreatic cancer	7.65e-05	0.000256	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3CA—pancreatic cancer	7.54e-05	0.000252	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TP53—pancreatic cancer	7.29e-05	0.000244	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—KRAS—pancreatic cancer	7.22e-05	0.000242	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3CA—pancreatic cancer	7.17e-05	0.00024	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKT1—pancreatic cancer	7.07e-05	0.000237	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HRAS—pancreatic cancer	6.97e-05	0.000234	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TP53—pancreatic cancer	6.94e-05	0.000232	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3CA—pancreatic cancer	6.64e-05	0.000222	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HRAS—pancreatic cancer	6.64e-05	0.000222	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TP53—pancreatic cancer	6.42e-05	0.000215	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKT1—pancreatic cancer	6.16e-05	0.000206	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HRAS—pancreatic cancer	6.14e-05	0.000206	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKT1—pancreatic cancer	5.86e-05	0.000196	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKT1—pancreatic cancer	5.42e-05	0.000182	CbGpPWpGaD
